期刊
MOLECULAR THERAPY-ONCOLYTICS
卷 14, 期 -, 页码 74-81出版社
CELL PRESS
DOI: 10.1016/j.omto.2019.03.011
关键词
-
资金
- China Scholarship Council
- German Cancer Aid [Deutsche Krebshilfe 111299]
- German Research Council (DFG) [HE 3186/15-1]
- Heidelberger Stiftung Chirurgie
- Dietmar Hopp-Stiftung
- Klaus Tschira Stiftung
- Hanns A. Pielenz-Stiftung
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal tumors, with poor therapeutic options in the advanced state. The broccoli-derived anti-inflammatory agent sulforaphane was shown to inhibit the progression of pancreatic cancer and other tumor entities. We examined the involvement of pancreatic cancer cell lines were evaluated by microRNA and gene expression arrays, bioinformatics, in silico analysis, qRT-PCR, western blotting, immunohistochemistry, in situ hybridization, self-renewal and differentiation assays, and in vivo xenograft studies. We selected the top nine differentially expressed microRNAs, and miR135b-5p was chosen as the most important candidate for the sulforaphane-induced upregulation of the tumor suppressor gene RASAL2. The expression of miR135b-5p and RASAL2 was almost absent in malignant pancreatic tissues and cell lines, but not in their normal counterparts. Lipofection of miR135b-5p enhanced RASAL2 expression and inhibited ERK1/2 signaling, viability, self-renewal capacity, and tumor growth. These results indicate that miR135b-5p acts as a tumor suppressor via the induction of RASAL2 in PDA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据